Cargando…
Correction to: Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469054/ https://www.ncbi.nlm.nih.gov/pubmed/30992058 http://dx.doi.org/10.1186/s13075-019-1887-x |
| _version_ | 1783411564825542656 |
|---|---|
| author | Tanaka, Yoshiya Wada, Kazuteru Takahashi, Yoshinori Hagino, Owen van Hoogstraten, Hubert Graham, Neil M. H. Kameda, Hideto |
| author_facet | Tanaka, Yoshiya Wada, Kazuteru Takahashi, Yoshinori Hagino, Owen van Hoogstraten, Hubert Graham, Neil M. H. Kameda, Hideto |
| author_sort | Tanaka, Yoshiya |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6469054 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-64690542019-04-23 Correction to: Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan Tanaka, Yoshiya Wada, Kazuteru Takahashi, Yoshinori Hagino, Owen van Hoogstraten, Hubert Graham, Neil M. H. Kameda, Hideto Arthritis Res Ther Correction BioMed Central 2019-04-16 2019 /pmc/articles/PMC6469054/ /pubmed/30992058 http://dx.doi.org/10.1186/s13075-019-1887-x Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Correction Tanaka, Yoshiya Wada, Kazuteru Takahashi, Yoshinori Hagino, Owen van Hoogstraten, Hubert Graham, Neil M. H. Kameda, Hideto Correction to: Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan |
| title | Correction to: Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan |
| title_full | Correction to: Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan |
| title_fullStr | Correction to: Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan |
| title_full_unstemmed | Correction to: Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan |
| title_short | Correction to: Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan |
| title_sort | correction to: sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase iii trial in japan |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469054/ https://www.ncbi.nlm.nih.gov/pubmed/30992058 http://dx.doi.org/10.1186/s13075-019-1887-x |
| work_keys_str_mv | AT tanakayoshiya correctiontosarilumabplusmethotrexateinpatientswithactiverheumatoidarthritisandinadequateresponsetomethotrexateresultsofarandomizedplacebocontrolledphaseiiitrialinjapan AT wadakazuteru correctiontosarilumabplusmethotrexateinpatientswithactiverheumatoidarthritisandinadequateresponsetomethotrexateresultsofarandomizedplacebocontrolledphaseiiitrialinjapan AT takahashiyoshinori correctiontosarilumabplusmethotrexateinpatientswithactiverheumatoidarthritisandinadequateresponsetomethotrexateresultsofarandomizedplacebocontrolledphaseiiitrialinjapan AT haginoowen correctiontosarilumabplusmethotrexateinpatientswithactiverheumatoidarthritisandinadequateresponsetomethotrexateresultsofarandomizedplacebocontrolledphaseiiitrialinjapan AT vanhoogstratenhubert correctiontosarilumabplusmethotrexateinpatientswithactiverheumatoidarthritisandinadequateresponsetomethotrexateresultsofarandomizedplacebocontrolledphaseiiitrialinjapan AT grahamneilmh correctiontosarilumabplusmethotrexateinpatientswithactiverheumatoidarthritisandinadequateresponsetomethotrexateresultsofarandomizedplacebocontrolledphaseiiitrialinjapan AT kamedahideto correctiontosarilumabplusmethotrexateinpatientswithactiverheumatoidarthritisandinadequateresponsetomethotrexateresultsofarandomizedplacebocontrolledphaseiiitrialinjapan |